Preparation method and thin-layer identification method of compound cottonrose hibiscus nasal ointment
Through low-temperature vacuum belt drying method and improved thin-layer identification method, the problems of uneven drying of elm extract powder in compound wood hibiscus nasal ointment and the identification of medicinal materials are solved, and product quality and detection accuracy are improved.
Patent Information
- Application Number
- CN202411146480.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-26
AI Technical Summary
The existing compound wood hibiscus nose ointment has too long and unevenness during the drying process of elm extract powder, which can easily breed microorganisms and affect product quality; the identification of elm medicinal materials has small separation and poor reproducibility, which affects the inspection results. ; Lack of identification and detection of medicinal herbs of hibiscus leaf.
The low-temperature vacuum belt drying method is used to shorten the drying time of elm extract powder, improve the thin-layer identification method of elm medicinal materials, and increase the thin-layer identification and detection of hibiscus leaves to ensure product quality and detection accuracy.
The product quality is improved through low-temperature vacuum belt drying method, the spot tailing and separation problems of elm medicinal materials are solved, the detection ability of wood hibiscus leaf medicinal materials is enhanced, and the product quality and testing standards are improved.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention relates to the field of drug preparation and detection, and in particular to a preparation method of compound hibiscus mutabilis nasal ointment and a thin layer identification method. Background Art
[0002] Compound Hibiscus nasal ointment is an exclusive Miao medicine product of Guizhou Liangji Pharmaceutical Co., Ltd. It has the effects of dispelling exterior pathogens, clearing away heat and detoxifying. It is used for nasal congestion, runny nose, sneezing, nasal burning and other symptoms caused by influenza and colds.
[0003] Compound Hibiscus mutabilis nasal ointment is included in the "State Drug Administration" WS-10591 (ZD-0591) -2002-2012Z, and the preparation method is as follows: take Hibiscus mutabilis leaves, add water and boil twice, each time for 1 hour, filter, combine the decoction, concentrate to a thick paste with a relative density of 1.30-1.32 (60°C) at normal pressure, add 0.5% potassium sorbate and mix well, and set aside; take Sanguisorba officinalis, crush into coarse powder, add water and boil for 1 hour, cool the filtrate to about 50°C, add salt, stir while adding, make the precipitation sufficient, let stand, filter, precipitate below 80°C, ventilate and dry, crush into very fine powder for use; take borneol and menthol separately, crush through a 60-mesh sieve, mix and stir until eutectic. Take the above-mentioned thick paste of Hibiscus mutabilis leaves and Sanguisorba officinalis extract powder, mix and stir with edible vinegar essence for 20 minutes, add the above-mentioned borneol and menthol eutectic, and mix evenly. Lanolin, white vaseline and paraffin are heated and melted respectively, sterilized at 100°C for 1 hour, then mixed evenly, cooled to 50°C, filtered through a 120-mesh sieve, mixed with the above-mentioned liquid medicine, stirred evenly, kept at 50°C, and stirred at high speed under reduced pressure for 30 minutes, then stirred and cooled to room temperature with conventional stirring, made into a specified amount, potted, sealed and packaged. The test contents are: properties; identification of Sanguisorba officinalis thin layer, identification of borneol and menthol thin layer; inspection; determination of borneol content. However, the following problems were found in actual production and testing: 1) Sanguisorba officinalis extract powder is dried by ventilation below 80°C, the drying time is too long, the sample is unevenly dried, microorganisms are easily bred, and the quality of Sanguisorba officinalis extract powder is affected; 2) In the identification experiment of Sanguisorba officinalis medicinal materials in the finished product quality standard, the spots are tailing, the separation is small, and the reproducibility is poor, which affects the judgment of the test results; 3) The finished product quality standard lacks the identification test of Hibiscus mutabilis leaf medicinal materials.
[0004] In order to solve the above problems, effectively improve product quality, and enhance the quality standards of compound hibiscus nasal ointment, Guizhou Liangji Pharmaceutical Co., Ltd. has revised it based on the company's actual situation and in combination with the quality standards of the "State Drug Administration"-WS-10591(ZD-0591)-2002-2012Z and the "Chinese Pharmacopoeia" 2020 edition. On the basis of the previous quality standards, the preparation method of compound hibiscus nasal ointment was revised; the thin layer identification method of Sanguisorba officinalis was revised; and the thin layer identification of hibiscus leaves was added. The purpose is to effectively detect the quality of compound hibiscus nasal ointment, improve product quality standards, effectively control product quality, and ensure the clinical efficacy of the product. Summary of the invention
[0005] The purpose of the invention is to provide an improved preparation method of compound hibiscus mutabilis nasal ointment.
[0006] Another object of the present invention is to provide an improved thin-layer identification method for compound Hibiscus mutabilis nasal ointment.
[0007] The prescription of the nasal ointment is as follows: 500g of hibiscus mutabilis leaves, 100g of sanguisorba officinalis, 40g of borneol, 20g of menthol, 80ml of edible vinegar essence, 40g of salt, 627g of lanolin, 50g of white vaseline and 70g of paraffin.
[0008] The preparation method of the improved compound Hibiscus mutabilis nasal ointment of the present invention comprises the following steps:
[0009] (1) Take the leaves of Hibiscus mutabilis from the above four herbs, add water and boil twice, each time for 1 hour, filter, combine the decoctions, and concentrate at normal pressure to a thick paste with a relative density of 1.30 at 60° C., add 0.5% potassium sorbate and mix well to obtain a thick paste of Hibiscus mutabilis leaves, which is set aside;
[0010] (2) Take the Sanguisorba officinalis, grind it into coarse powder, add water and boil for 1 hour, cool the filtrate to about 50°C, add salt, stir while adding, make the precipitation complete, let it stand, filter, and low-temperature vacuum belt drying to obtain Sanguisorba officinalis extract powder, which is set aside;
[0011] (3) Take borneol and menthol, crush them through a 60-mesh sieve, and mix and stir until they become a co-melt;
[0012] (4) Take the above-mentioned Hibiscus mutabilis leaf paste and Sanguisorba officinalis extract powder, mix them with edible vinegar essence and stir for 20 minutes, add borneol and menthol eutectic to make the mixture evenly mixed;
[0013] (5) After the lanolin, white vaseline and paraffin are heated and melted respectively, they are sterilized at 100°C for 1 hour, then mixed evenly, cooled to 50°C, filtered through a 120-mesh sieve, and then mixed with the above-mentioned drug solution, stirred evenly, kept at 50°C, and stirred at high speed under reduced pressure for 30 minutes, and then cooled to room temperature with conventional stirring, made into a specified amount, potted, sealed, and packaged.
[0014] Preferably,
[0015] The low-temperature vacuum belt drying in step (2) of the improved preparation method of the compound Hibiscus mutabilis nasal ointment of the present invention has the following specific conditions: drying temperature 20°C-80°C, vacuum degree -0.075Mpa, crawler speed 130-150mm / min, feed pump 30-40Hz, and crushing frequency 30Hz-50Hz.
[0016] More preferably,
[0017] The low-temperature vacuum belt drying in step (2) of the improved method for preparing the compound Hibiscus mutabilis nasal ointment of the present invention has the following specific conditions: drying temperature 60° C., vacuum degree -0.075 MPa, crawler speed 135 mm / min, feed pump 40 Hz, and crushing frequency 40 Hz.
[0018] The thin layer identification of the nasal ointment of the present invention includes the thin layer identification of Sanguisorba officinalis leaves and the thin layer identification of Hibiscus mutabilis leaves.
[0019] The thin-layer identification method of the present invention is as follows: weigh 15-25g of a sample of the compound Hibiscus mutabilis nasal ointment, add 20-40mL of methanol, heat and reflux at 60-100°C for 30-60min, filter, evaporate the filtrate to dryness, add purified water to the residue and disperse it in warm water, apply it to a D-101 macroporous resin column, first wash it with purified water until there is no turbidity, then elute it with 50% and 75% ethanol 100mL each, collect the 75% ethanol eluate, evaporate to dryness, add 5-10mL of methanol to the residue to dissolve it, and obtain a test solution; take 2g of the reference medicinal material of the Sanguisorba officinalis, and add 50-10mL of methanol to dissolve it in the same manner as the test solution. Preparation method of liquid: prepare a reference medicinal material solution; take an appropriate amount of Sanguisorba officinalis saponin reference substance, add methanol to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, take 1-3 μl of the test solution, the reference medicinal material solution and the reference substance solution, respectively, and spot them on the same silica gel G plate, use ethyl acetate-methanol-water with a ratio of 7:1:0.2 as a developing solvent, develop, take out, dry, spray with 5% phosphomolybdic acid ethanol solution, and develop at 105°C. In the test sample chromatogram, spots of the same color appear at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0020] Preferably, the thin-layer identification method of the Sanguisorba officinalis is as follows: weigh 15-20g of the compound Hibiscus mutabilis nasal ointment sample, add 20-30mL of methanol, heat and reflux at 60-80°C for 30-40min, filter, evaporate the filtrate to dryness, disperse the residue in pure water, apply it to a D-101 macroporous resin column, first wash with pure water until there is no turbidity, then elute with 50% and 75% ethanol 100mL each, collect the 75% ethanol eluate, evaporate to dryness, add 5-8mL of methanol to the residue to dissolve, and obtain a test solution; take 2g of the Sanguisorba officinalis reference medicinal material, and dissolve it in the same solution as the test solution. Preparation method of liquid: prepare a reference medicinal material solution; take an appropriate amount of Sanguisorba officinalis saponin reference substance, add methanol to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, take 1-2 μl of the test solution, the reference medicinal material solution and the reference substance solution, respectively, and spot them on the same silica gel G plate, use ethyl acetate-methanol-water with a ratio of 7:1:0.2 as a developing solvent, develop, take out, dry, spray with 5% phosphomolybdic acid ethanol solution, and develop at 105°C. In the test sample chromatogram, spots of the same color appear at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0021] Further preferably, the Sanguisorba officinalis thin layer identification method is: weigh 20g of compound Hibiscus mutabilis nasal ointment sample, add 30mL of methanol, heat and reflux at 80°C for 40min, filter, evaporate the filtrate to dryness, disperse the residue in pure water, apply it to a D-101 macroporous resin column, first wash with pure water until there is no turbidity, then elute with 50% and 75% ethanol 100mL each, collect 75% ethanol eluate, evaporate to dryness, add 5mL of methanol to dissolve the residue, and obtain a test solution; take 2g of Sanguisorba officinalis reference medicinal material, and prepare the test solution in the same way as the preparation method of the test solution The control medicinal material solution was prepared by the method; an appropriate amount of Sanguisorba officinalis saponin reference substance was taken, and methanol was added to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, 1 μl of the test solution, the control medicinal material solution and the reference substance solution were respectively spotted on the same silica gel G plate, and ethyl acetate-methanol-water with a ratio of 7:1:0.2 was used as the developing solvent, and the plate was developed, taken out, dried, sprayed with 5% phosphomolybdic acid ethanol solution, and color was developed at 105°C. In the test sample chromatogram, spots of the same color appeared at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0022] The identification method of the Hibiscus mutabilis leaf medicinal material of the present invention is as follows: 15-25g of the compound Hibiscus mutabilis leaf ointment is taken, 25-35mL of methanol is added, and after refluxing at 60-100°C for 20-40 minutes, the mixture is filtered, 10mL of pure water is added after the filtrate is evaporated, and the mixture is extracted twice with petroleum ether at 30-60°C, the petroleum ether layer is removed, and then the mixture is extracted twice with ethyl acetate, each time with 5-15mL, to obtain a test solution; 20g of the control medicinal material of Hibiscus mutabilis leaf is taken, and a control medicinal material solution is prepared in the same manner as the preparation method of the test solution; an appropriate amount of rutin reference substance is taken, and methanol is added; A 0.1 mg / mL standard solution is prepared; according to the thin layer chromatography test, 1-3 μl of the test solution, the control medicinal material solution and the control substance solution are respectively spotted on the same polyamide film plate, and ethyl acetate-methanol-water-glacial acetic acid in a ratio of 15:5:1:1 is used as a developing agent, and the plate is developed, taken out, dried, sprayed with 3% trichloroaluminum ethanol solution, blown dry with a hair dryer, and detected at UV light 365 nm; in the test sample chromatogram, fluorescent spots of the same color are shown at the corresponding positions of the control medicinal material chromatogram and the control substance chromatogram.
[0023] Preferably, the identification method of the Hibiscus mutabilis leaf medicinal material is as follows: 15-20g of the compound Hibiscus mutabilis leaf ointment is taken, 25-30mL of methanol is added, and after refluxing at 60-80°C for 20-30 minutes, the mixture is filtered, 10mL of purified water is added after the filtrate is evaporated, and the mixture is extracted twice with petroleum ether at 30-60°C, the petroleum ether layer is removed, and then extracted twice with ethyl acetate, 5-10mL each time, to obtain a test solution; 20g of the control medicinal material of Hibiscus mutabilis leaf is taken, and a control medicinal material solution is prepared in the same manner as the preparation method of the test solution; an appropriate amount of rutin reference substance is taken, and methanol is added; A 0.1 mg / mL standard solution is prepared; according to the thin layer chromatography test, 1-2 μl of the test solution, the control medicinal material solution and the reference substance solution are respectively spotted on the same polyamide film plate, and ethyl acetate-methanol-water-glacial acetic acid in a ratio of 15:5:1:1 is used as a developing agent, and the plate is developed, taken out, dried, sprayed with 3% trichloroaluminum ethanol solution, blown dry with a hair dryer, and detected under UV light at 365 nm; in the test sample chromatogram, fluorescent spots of the same color are shown at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0024] Further preferred. The identification method of the Hibiscus mutabilis leaf medicinal material is as follows: take 20g of the compound Hibiscus mutabilis leaf ointment, add 30mL of methanol, reflux at 80°C for 30 minutes, filter, evaporate the filtrate and add 10mL of pure water, extract twice with petroleum ether at 30-60°C, remove the petroleum ether layer, and then extract twice with ethyl acetate, 10mL each time, to obtain the test solution; take 20g of the Hibiscus mutabilis leaf control medicinal material, and prepare the control medicinal material solution in the same way as the preparation method of the test solution; take an appropriate amount of rutin reference substance, add methanol to make 0.1mg / m L of standard solution; according to the thin layer chromatography test, 1-3 μl of the test solution, the control medicinal material solution and the reference substance solution are respectively spotted on the same polyamide film plate, and ethyl acetate-methanol-water-glacial acetic acid with a ratio of 15:5:1:1 is used as the developing agent, the plate is developed, taken out, dried, sprayed with 3% trichloroaluminum ethanol solution, blown dry with a hair dryer, and detected under UV light at 365nm; in the test sample chromatogram, fluorescent spots of the same color are shown at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0025] Beneficial Effects
[0026] 1. The low-temperature vacuum belt drying method is adopted in the drying stage of the Sanguisorba officinalis extract powder of the present invention, which shortens the drying time, prevents the breeding of bacteria, prevents the phenomenon of uneven drying, and ensures the product quality.
[0027] 2. The low-temperature vacuum belt drying method of the Sanguisorba officinalis extract powder of the present invention passed the inspections of drying temperature, track speed, feed pump frequency, crushing frequency, drying time, etc., and the gallic acid content was used as the screening criterion, and the optimal solution was obtained as follows: drying temperature 60°C, vacuum degree -0.075Mpa, track speed 135mm / min, feed pump 40Hz, crushing frequency 40Hz, and drying time 1h.
[0028] 3. The present invention solves the technical problems of tailing spots, small separation and poor reproducibility in the identification of Sanguisorba officinalis medicinal materials, adds thin layer identification detection of Hibiscus mutabilis leaf medicinal materials, ensures the quality of the original medicinal materials, is more conducive to ensuring the quality of the products, and improves the detection standards.
[0029] 4. The thin-layer identification method of the medicinal material Sanguisorba officinalis of the present invention has been tested with a developing agent, a color developer, and a silica gel plate to obtain a thin-layer method for the medicinal material Sanguisorba officinalis. In the 10 batches of samples tested, spots of the same color were shown on the silica gel G plate at positions corresponding to the reference substance and the reference medicinal material, indicating good reproducibility; the method has passed the specificity investigation, and the results show that in the tested samples, spots of the same color were shown at positions corresponding to the reference substance and the reference medicinal material, and the spots were well separated, with no negative interference; the method has passed the temperature and humidity methodology investigation, and the results show that spots of the same color were shown at corresponding positions in the chromatogram of the test sample, the chromatogram of the reference medicinal material, and the chromatogram of the reference substance, and the comprehensive spot color size and dot separation prove that better identification chromatograms can be obtained under different temperature and humidity conditions.
[0030] 5. The thin-layer identification method of Hibiscus mutabilis leaf medicinal material of the present invention has been tested with a developing agent, a color developer, and a silica gel plate to obtain a thin-layer method for Sanguisorba officinalis medicinal material. In the 10 batches of samples tested, fluorescent spots of the same color were shown on the polyamide film plate at positions corresponding to the reference substance and the reference medicinal material, indicating good reproducibility; the method has passed the specificity investigation, and the results show that in the tested samples, fluorescent spots of the same color were shown at positions corresponding to the reference substance and the reference medicinal material, and the spot separation was good, and there was no negative interference; the method has passed the temperature and humidity methodology investigation, and the results show that fluorescent spots of the same color are shown at corresponding positions in the chromatogram of the test sample, the chromatogram of the reference medicinal material, and the chromatogram of the reference substance, and the comprehensive spot color size and dot separation prove that better identification chromatograms can be obtained under different temperature and humidity conditions. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 Thin layer diagram of different developing agents for investigation of Sanguisorba officinalis (1 in the figure is the test sample; 2 is the Sanguisorba officinalis reference medicinal material; 3 is the Sanguisorba officinalis saponin reference substance);
[0032] Figure 2 Thin layer diagram of different color developing agents for Sanguisorba officinalis (1 is the test sample; 2 is the Sanguisorba officinalis reference medicinal material; 3 is the Sanguisorba officinalis saponin reference product);
[0033] Figure 3 Thin layer diagram of different silica gel plates for investigation of Sanguisorba officinalis (1 is the test product; 2 is the Sanguisorba officinalis reference medicinal material; 3 is the Sanguisorba officinalis saponin reference product);
[0034] Figure 4 Reproducible thin-layer graph of Sanguisorba officinalis (1-12 in the figure represent: 20230901, 20230902, 20230903, 20230904, 20230905, 20230906, 20230907, 20230908, 20230909, 20230910, Sanguisorba officinalis reference medicinal material, Sanguisorba officinalis saponin reference substance);
[0035] Figure 5Thin layer diagram of moisture-specific properties of Sanguisorba officinalis (in the figure, 1 represents the test sample, 2 represents the Sanguisorba officinalis reference medicinal material; 3 represents the Sanguisorba officinalis saponin reference substance, and 4 represents the negative sample);
[0036] Figure 6 Thin layer chart of the durability of Sanguisorba officinalis (thin layer plate of Qingdao Ocean Chemical Co., Ltd., in the figure, 1 is the test sample, 2 is the Sanguisorba officinalis reference medicinal material; 3 is the Sanguisorba officinalis saponin reference product);
[0037] Figure 7 The durability thin layer chart of Sanguisorba officinalis (thin layer plate of Sinopharm Chemical Testing Co., Ltd., in which 1 is the test sample, 2 is the Sanguisorba officinalis reference medicinal material; 3 is the Sanguisorba officinalis saponin reference product);
[0038] Figure 8 Thin layer inspection of Sanguisorba officinalis with a humidity of 43% (1 in the figure is the test sample, 2 is the Sanguisorba officinalis reference medicinal material; 3 is the Sanguisorba officinalis saponin reference substance);
[0039] Fig. 9 Thin layer inspection of Sanguisorba officinalis with a humidity of 73% (1 in the figure is the test sample, 2 is the Sanguisorba officinalis reference medicinal material; 3 is the Sanguisorba officinalis saponin reference substance);
[0040] Fig.10 Thin layer inspection of Sanguisorba officinalis at a temperature of 4°C (1 in the figure is the test sample, 2 is the Sanguisorba officinalis reference medicinal material; 3 is the Sanguisorba officinalis saponin reference product);
[0041] Fig.11 Thin layer inspection of Sanguisorba officinalis at 20°C (1 in the figure is the test sample, 2 is the Sanguisorba officinalis reference medicinal material; 3 is the Sanguisorba officinalis saponin reference substance);
[0042] Fig.12 Thin layer diagram of different developing agents for Hibiscus mutabilis leaves (1 is the test sample; 2 is the rutin reference substance; 3 is the reference medicinal material of Hibiscus mutabilis leaves);
[0043] Fig.13 Thin layer diagram of different color developing agents for Hibiscus mutabilis leaves (1 is the test sample; 2 is the rutin reference substance; 3 is the reference medicinal material of Hibiscus mutabilis leaves);
[0044] Fig.14 Thin layer diagram of different silica gel plates for Hibiscus mutabilis leaves (1 in the figure is the test sample; 2 is the rutin reference substance; 3 is the reference medicinal material of Hibiscus mutabilis leaves);
[0045] Fig.15 Reproducible thin-layer diagram of Hibiscus mutabilis leaf (1-12 in the figure represent: 20230901, 20230902, 20230903, 20230904, 20230905, 20231001, 20231002, 20231003, 20231004, 20231005, rutin reference; Hibiscus mutabilis leaf reference medicinal material);
[0046] Fig.16 Specific thin layer chromatography of Hibiscus mutabilis leaves (1 is the test sample, 2 is the rutin reference sample; 3 is the Hibiscus mutabilis leaf reference medicinal material, and 4 is the negative sample);
[0047] Fig.17 Temperature thin layer investigation diagram of Hibiscus mutabilis leaves (1 is the test sample, 2 is the rutin reference substance; 3 is the Hibiscus mutabilis leaf reference medicinal material, and 4 is the negative sample);
[0048] Fig.18 Temperature thin layer test diagram of Hibiscus mutabilis leaves (in the figure, 1 is the test sample, 2 is the rutin reference substance; 3 is the Hibiscus mutabilis leaf reference medicinal material, and 4 is the negative sample). DETAILED DESCRIPTION
[0049] The technical solution of the present invention is further described in detail below through specific embodiments.
[0050] Example 1
[0051] Recipe: 500g of hibiscus leaves, 100g of sanguisorba officinalis, 40g of borneol, 20g of menthol, 80ml of edible vinegar essence, 40g of salt, 627g of lanolin, 50g of white vaseline, and 70g of paraffin.
[0052] Preparation method:
[0053] (1) Take the leaves of Hibiscus mutabilis from the above four herbs, add water and boil twice, each time for 1 hour, filter, combine the decoctions, and concentrate at normal pressure to a thick paste with a relative density of 1.30 at 60° C., add 0.5% potassium sorbate and mix well to obtain a thick paste of Hibiscus mutabilis leaves, which is set aside;
[0054] (2) Take the Sanguisorba officinalis, grind it into coarse powder, add water and boil for 1 hour, cool the filtrate to about 50° C., add salt, stir while adding, make the precipitation sufficient, let it stand, filter, and precipitate low-temperature vacuum belt drying (drying temperature 60° C., vacuum degree -0.075 MPa, crawler speed 135 mm / min, feed pump 40 Hz, grinding frequency 40 Hz) to obtain Sanguisorba officinalis extract powder, which is set aside;
[0055] (3) Take borneol and menthol, crush them through a 60-mesh sieve, and mix and stir until they become a co-melt;
[0056] (4) Take the above-mentioned Hibiscus mutabilis leaf paste and Sanguisorba officinalis extract powder, mix them with edible vinegar essence and stir for 20 minutes, add borneol and menthol eutectic to make the mixture evenly mixed;
[0057] (5) After the lanolin, white vaseline and paraffin are heated and melted respectively, they are sterilized at 100°C for 1 hour, then mixed evenly, cooled to 50°C, filtered through a 120-mesh sieve, and then mixed with the above-mentioned drug solution, stirred evenly, kept at 50°C, and stirred at high speed under reduced pressure for 30 minutes, and then cooled to room temperature with conventional stirring, made into a specified amount, potted, sealed, and packaged.
[0058] Example 2
[0059] Recipe: Same as Example 1.
[0060] Preparation method:
[0061] (1) Take the leaves of Hibiscus mutabilis from the above four herbs, add water and boil twice, each time for 1 hour, filter, combine the decoctions, and concentrate at normal pressure to a thick paste with a relative density of 1.30 at 60° C., add 0.5% potassium sorbate and mix well to obtain a thick paste of Hibiscus mutabilis leaves, which is set aside;
[0062] (2) Take the Sanguisorba officinalis, grind it into coarse powder, add water and boil for 1 hour, cool the filtrate to about 50° C., add salt, stir while adding, make the precipitation sufficient, let it stand, filter, and low-temperature vacuum belt drying (drying temperature 20° C., vacuum degree -0.075 MPa, crawler speed 130 mm / min, feed pump 30 Hz, grinding frequency 30 Hz) to obtain Sanguisorba officinalis extract powder, which is set aside;
[0063] (3) Take borneol and menthol, crush them through a 60-mesh sieve, and mix and stir until they become a co-melt;
[0064] (4) Take the above-mentioned Hibiscus mutabilis leaf paste and Sanguisorba officinalis extract powder, mix them with edible vinegar essence and stir for 20 minutes, add borneol and menthol eutectic to make the mixture evenly mixed;
[0065] (5) After the lanolin, white vaseline and paraffin are heated and melted respectively, they are sterilized at 100°C for 1 hour, then mixed evenly, cooled to 50°C, filtered through a 120-mesh sieve, and then mixed with the above-mentioned drug solution, stirred evenly, kept at 50°C, and stirred at high speed under reduced pressure for 30 minutes, and then cooled to room temperature with conventional stirring, made into a specified amount, potted, sealed, and packaged.
[0066] Example 3
[0067] Recipe: Same as Example 1.
[0068] Preparation method:
[0069] (1) Take the leaves of Hibiscus mutabilis from the above four herbs, add water and boil twice, each time for 1 hour, filter, combine the decoctions, and concentrate at normal pressure to a thick paste with a relative density of 1.30 at 60° C., add 0.5% potassium sorbate and mix well to obtain a thick paste of Hibiscus mutabilis leaves, which is set aside;
[0070] (2) Take the Sanguisorba officinalis, grind it into coarse powder, add water and boil for 1 hour, cool the filtrate to about 50° C., add salt, stir while adding, make the precipitation sufficient, let it stand, filter, and low-temperature vacuum belt drying (drying temperature 80° C., vacuum degree -0.075 MPa, crawler speed 150 mm / min, feed pump 40 Hz, grinding frequency 50 Hz) to obtain Sanguisorba officinalis extract powder, which is set aside;
[0071] (3) Take borneol and menthol, crush them through a 60-mesh sieve, and mix and stir until they become a co-melt;
[0072] (4) Take the above-mentioned Hibiscus mutabilis leaf paste and Sanguisorba officinalis extract powder, mix them with edible vinegar essence and stir for 20 minutes, add borneol and menthol eutectic to make the mixture evenly mixed;
[0073] (5) After the lanolin, white vaseline and paraffin are heated and melted respectively, they are sterilized at 100°C for 1 hour, then mixed evenly, cooled to 50°C, filtered through a 120-mesh sieve, and then mixed with the above-mentioned drug solution, stirred evenly, kept at 50°C, and stirred at high speed under reduced pressure for 30 minutes, and then cooled to room temperature with conventional stirring, made into a specified amount, potted, sealed, and packaged.
[0074] Example 4
[0075] Recipe: Same as Example 1.
[0076] Preparation method:
[0077] (1) Take the leaves of Hibiscus mutabilis from the above four herbs, add water and boil twice, each time for 1 hour, filter, combine the decoctions, and concentrate at normal pressure to a thick paste with a relative density of 1.30 at 60° C., add 0.5% potassium sorbate and mix well to obtain a thick paste of Hibiscus mutabilis leaves, which is set aside;
[0078] (2) Take the Sanguisorba officinalis, grind it into coarse powder, add water and boil for 1 hour, cool the filtrate to about 50° C., add salt, stir while adding, make the precipitation sufficient, let it stand, filter, and low-temperature vacuum belt drying (drying temperature 45° C., vacuum degree -0.075 MPa, crawler speed 140 mm / min, feed pump 35 Hz, grinding frequency 35 Hz) to obtain Sanguisorba officinalis extract powder, which is set aside;
[0079] (3) Take borneol and menthol, crush them through a 60-mesh sieve, and mix and stir until they become a co-melt;
[0080] (4) Take the above-mentioned Hibiscus mutabilis leaf paste and Sanguisorba officinalis extract powder, mix them with edible vinegar essence and stir for 20 minutes, add borneol and menthol eutectic to make the mixture evenly mixed;
[0081] (5) After the lanolin, white vaseline and paraffin are heated and melted respectively, they are sterilized at 100°C for 1 hour, then mixed evenly, cooled to 50°C, filtered through a 120-mesh sieve, and then mixed with the above-mentioned drug solution, stirred evenly, kept at 50°C, and stirred at high speed under reduced pressure for 30 minutes, and then cooled to room temperature with conventional stirring, made into a specified amount, potted, sealed, and packaged.
[0082] The compound Hibiscus mutabilis nasal ointment prepared in Examples 1 to 4 was tested by the thin layer identification method of Examples 5 to 9 respectively:
[0083] Example 5
[0084] (1) Thin layer identification of Radix Sanguisorbae: Weigh 20 g of compound Hibiscus mutabilis nasal ointment sample, add 30 mL of methanol, heat and reflux at 80°C for 40 min, filter, evaporate the filtrate to dryness, disperse the residue with purified water, apply it to a D-101 macroporous resin column, first wash with purified water until there is no turbidity, then elute with 100 mL of 50% and 75% ethanol respectively, collect the 75% ethanol eluate, evaporate to dryness, add 5 mL of methanol to dissolve the residue, and obtain the test solution; take 2 g of Radix Sanguisorbae control medicinal material, and prepare the same method as the test solution Control medicinal material solution; take an appropriate amount of Sanguisorba officinalis saponin reference substance, add methanol to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, take 1 μl of the test solution, the control medicinal material solution and the reference substance solution, respectively, and spot them on the same silica gel G plate, use ethyl acetate-methanol-water with a ratio of 7:1:0.2 as the developing solvent, develop, take out, dry, spray with 5% phosphomolybdic acid ethanol solution, and develop color at 105°C. In the test sample chromatogram, spots of the same color appear at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0085] (2) Thin layer identification of Hibiscus mutabilis leaf medicinal material: Take 20 g of compound Hibiscus mutabilis leaf ointment, add 30 mL of methanol, reflux at 80°C for 30 minutes, filter, evaporate the filtrate, add 10 mL of purified water, extract twice with petroleum ether (30-60°C), remove the petroleum ether layer, and then extract twice with ethyl acetate, 10 mL each time, to obtain the test solution; take 20 g of Hibiscus mutabilis leaf control medicinal material, and prepare the control medicinal material solution in the same way as the preparation method of the test solution; take an appropriate amount of rutin reference substance, add methanol to make a 0.1 mg / ml mL of standard solution; according to the thin layer chromatography test, 1-3 μl of the test solution, the control medicinal material solution and the reference substance solution are respectively spotted on the same polyamide film plate, and ethyl acetate-methanol-water-glacial acetic acid with a ratio of 15:5:1:1 is used as the developing agent, and the plate is developed, taken out, dried, sprayed with 3% trichloroaluminum ethanol solution, blown dry with a hair dryer, and detected under UV light at 365nm; in the test sample chromatogram, fluorescent spots of the same color appear at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0086] Example 6
[0087] (1) Thin layer identification of Sanguisorba officinalis: Weigh 15 g of compound Hibiscus mutabilis nasal ointment sample, add 20 mL of methanol, heat and reflux at 60°C for 30 min, filter, evaporate the filtrate to dryness, disperse the residue with purified water, apply it to a D-101 macroporous resin column, first wash with purified water until there is no turbidity, then elute with 50% and 75% ethanol 100 mL each, collect the 75% ethanol eluate, evaporate to dryness, add 5 mL of methanol to dissolve the residue, and obtain the test solution; take 2 g of Sanguisorba officinalis control medicinal material, and prepare the same method as the test solution Control medicinal material solution; take an appropriate amount of Sanguisorba officinalis saponin reference substance, add methanol to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, take 1 μl of the test solution, the control medicinal material solution and the reference substance solution, respectively, and spot them on the same silica gel G plate, use ethyl acetate-methanol-water with a ratio of 7:1:0.2 as the developing solvent, develop, take out, dry, spray with 5% phosphomolybdic acid ethanol solution, and develop color at 105°C. In the test sample chromatogram, spots of the same color appear at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0088] (2) Thin layer identification of Hibiscus mutabilis leaf medicinal material: Take 15g of compound Hibiscus mutabilis leaf ointment, add 25mL of methanol, reflux at 60℃ for 20 minutes, filter, evaporate the filtrate, add 10mL of purified water, extract twice with petroleum ether (30-60℃), remove the petroleum ether layer, and then extract twice with ethyl acetate, 5mL each time, to obtain the test solution; take 20g of Hibiscus mutabilis leaf control medicinal material, and prepare the control medicinal material solution in the same way as the preparation method of the test solution; take an appropriate amount of rutin reference substance, add methanol to make 0.1mg / mL of standard solution; according to the thin layer chromatography test, 1μl of the test solution, control medicinal material solution and reference substance solution were taken and spotted on the same polyamide film plate respectively, and ethyl acetate-methanol-water-glacial acetic acid with a ratio of 15:5:1:1 was used as the developing agent, the plate was developed, taken out, dried, sprayed with 3% trichloroaluminum ethanol solution, dried with a hair dryer, and detected under UV light at 365nm; in the test sample chromatogram, fluorescent spots of the same color appeared at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0089] Example 7
[0090] (1) Thin layer identification of Radix Sanguisorbae: Weigh 25 g of compound Hibiscus mutabilis nasal ointment sample, add 40 mL of methanol, heat and reflux at 100°C for 60 min, filter, evaporate the filtrate to dryness, disperse the residue with purified water, apply it to a D-101 macroporous resin column, first wash with purified water until there is no turbidity, then elute with 50% and 75% ethanol 100 mL each, collect the 75% ethanol eluate, evaporate to dryness, add 10 mL of methanol to dissolve the residue, and obtain the test solution; take 2 g of Radix Sanguisorbae control medicinal material, and prepare the same method as the test solution preparation method. Prepare a reference medicinal material solution; take an appropriate amount of Sanguisorba officinalis saponin reference substance, add methanol to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, take 3 μl of the test solution, the reference medicinal material solution and the reference substance solution, respectively, and spot them on the same silica gel G plate, use ethyl acetate-methanol-water with a ratio of 7:1:0.2 as the developing solvent, develop, take out, dry, spray with 5% phosphomolybdic acid ethanol solution, and develop color at 105°C. In the test sample chromatogram, spots of the same color appear at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0091] (2) Thin layer identification of Hibiscus mutabilis leaf medicinal material: Take 25 g of compound Hibiscus mutabilis leaf ointment, add 35 mL of methanol, reflux at 100°C for 40 minutes, filter, evaporate the filtrate, add 10 mL of purified water, extract twice with petroleum ether (30-60°C), remove the petroleum ether layer, and then extract twice with ethyl acetate, 15 mL each time, to obtain the test solution; take 20 g of Hibiscus mutabilis leaf control medicinal material, and prepare the control medicinal material solution in the same way as the preparation method of the test solution; take an appropriate amount of rutin reference substance, add methanol to make a 0.1 M g / mL standard solution; according to the thin layer chromatography test, 3μl of the test solution, control medicinal material solution and reference substance solution are respectively spotted on the same polyamide film plate, and ethyl acetate-methanol-water-glacial acetic acid with a ratio of 15:5:1:1 is used as the developing agent, and the plate is developed, taken out, dried, sprayed with 3% trichloroaluminum ethanol solution, blown dry with a hair dryer, and detected under UV light 365nm; in the test sample chromatogram, fluorescent spots of the same color are shown at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0092] Example 8
[0093] (1) Thin layer identification of Sanguisorba officinalis: Weigh 15-25g of compound Hibiscus mutabilis nasal ointment sample, add 25mL of methanol, heat and reflux at 70℃ for 35min, filter, evaporate the filtrate to dryness, disperse the residue with purified water under warm conditions, apply it to a D-101 macroporous resin column, first wash with purified water until there is no turbidity, then elute with 50% and 75% ethanol 100mL each, collect 50% ethanol eluate, evaporate to dryness, add 6mL of methanol to dissolve the residue, and obtain a test solution; take 2g of Sanguisorba officinalis control medicinal material, and prepare the test solution in the same way as the test solution Prepare a reference medicinal material solution; take an appropriate amount of Sanguisorba officinalis saponin reference substance, add methanol to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, take 2 μl of the test solution, the reference medicinal material solution and the reference substance solution, respectively, and spot them on the same silica gel G plate, use ethyl acetate-methanol-water with a ratio of 7:1:0.2 as the developing solvent, develop, take out, dry, spray with 5% phosphomolybdic acid ethanol solution, and develop at 105°C. In the test sample chromatogram, spots of the same color appear at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0094] (2) Thin layer identification of Hibiscus mutabilis leaf medicinal material: Take 20 g of compound Hibiscus mutabilis leaf ointment, add 28 mL of methanol, reflux at 70°C for 25 minutes, filter, evaporate the filtrate, add 10 mL of purified water, extract twice with petroleum ether (30-60°C), remove the petroleum ether layer, and then extract twice with ethyl acetate, 10 mL each time, to obtain the test solution; take 20 g of Hibiscus mutabilis leaf control medicinal material, and prepare the control medicinal material solution in the same way as the preparation method of the test solution; take an appropriate amount of rutin reference substance, add methanol to make 0.1 mg / mL of standard solution; according to the thin layer chromatography test, 2μl of the test solution, control medicinal material solution and reference substance solution were respectively spotted on the same polyamide film plate, and ethyl acetate-methanol-water-glacial acetic acid with a ratio of 15:5:1:1 was used as the developing agent. The plate was developed, taken out, dried, sprayed with 3% trichloroaluminum ethanol solution, dried with a hair dryer, and detected under UV light at 365nm; in the test sample chromatogram, fluorescent spots of the same color appeared at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0095] Example 9
[0096] (1) Thin layer identification of Radix Sanguisorbae: Weigh 20 g of compound Hibiscus mutabilis nasal ointment sample, add 35 mL of methanol, heat and reflux at 90°C for 50 min, filter, evaporate the filtrate to dryness, disperse the residue with purified water, apply it to a D-101 macroporous resin column, first wash with purified water until there is no turbidity, then elute with 100 mL of 50% and 75% ethanol respectively, collect the 75% ethanol eluate, evaporate to dryness, add 8 mL of methanol to dissolve the residue, and obtain the test solution; take 2 g of Radix Sanguisorbae control medicinal material, and prepare the same method as the test solution Control medicinal material solution; take an appropriate amount of Sanguisorba officinalis saponin reference substance, add methanol to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, take 2 μl of the test solution, the control medicinal material solution and the reference substance solution, respectively, and spot them on the same silica gel G plate, use ethyl acetate-methanol-water with a ratio of 7:1:0.2 as the developing solvent, develop, take out, dry, spray with 5% phosphomolybdic acid ethanol solution, and develop color at 105°C. In the test sample chromatogram, spots of the same color appear at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0097] (2) Thin layer identification of Hibiscus mutabilis leaf medicinal material: Take 20 g of compound Hibiscus mutabilis leaf ointment, add 30 mL of methanol, reflux at 90°C for 25 minutes, filter, evaporate the filtrate, add 10 mL of purified water, extract twice with petroleum ether (30-60°C), remove the petroleum ether layer, and then extract twice with ethyl acetate, 10 mL each time, to obtain the test solution; take 20 g of Hibiscus mutabilis leaf control medicinal material, and prepare the control medicinal material solution in the same way as the preparation method of the test solution; take an appropriate amount of rutin reference substance, add methanol to make 0.1 mg / mL of standard solution; according to the thin layer chromatography test, 1μl of the test solution, control medicinal material solution and reference substance solution were taken and spotted on the same polyamide film plate respectively, and ethyl acetate-methanol-water-glacial acetic acid with a ratio of 15:5:1:1 was used as the developing agent, the plate was developed, taken out, dried, sprayed with 3% trichloroaluminum ethanol solution, dried with a hair dryer, and detected under UV light at 365nm; in the test sample chromatogram, fluorescent spots of the same color appeared at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
[0098] In order to further verify the effectiveness of the present invention, the inventor conducted a series of verification experiments, the excerpts of which are as follows:
[0099] Experimental Example 1
[0100] 1. Prescription
[0101] 500g of Hibiscus mutabilis leaves, 100g of Sanguisorba officinalis, 40g of borneol, 20g of menthol, 80ml of edible vinegar essence, 40g of salt, 627g of lanolin, 50g of white vaseline, and 70g of paraffin.
[0102] 2. Preparation method
[0103] Standard before revision: Take Hibiscus mutabilis leaves, add water and boil twice, each time for 1 hour, filter, combine the decoction, concentrate at normal pressure to a thick paste with a relative density of 1.30-1.32 (60°C), add 0.5% potassium sorbate and mix well, and set aside; take Sanguisorba officinalis, grind into coarse powder, add water and boil for 1 hour, cool the filtrate to about 50°C, add salt, stir while adding, make the precipitation sufficient, let stand, filter, precipitate is ventilated and dried below 80°C, grind into very fine powder for use; take Borneol and menthol separately, grind through a 60-mesh sieve, mix and stir until eutectic. Take the above-mentioned thick paste of Hibiscus mutabilis leaves and Sanguisorba officinalis extract powder, mix and stir with edible vinegar essence for 20 minutes, add the above-mentioned Borneol and menthol eutectic, and mix well. After the lanolin, white vaseline and paraffin are heated and melted respectively, they are sterilized at 100°C for 1 hour, then mixed evenly, cooled to 50°C, filtered through a 120-mesh sieve, and then mixed with the above-mentioned medicinal solution, stirred evenly, kept warm at 50°C, stirred at high speed under reduced pressure for 30 minutes, then cooled to room temperature with conventional stirring, made into a specified amount, potted, sealed and packaged.
[0104] Results: In the long-term production process, it was found that the Sanguisorba officinalis extract powder was dried with ventilation at a temperature below 80℃, the drying time was too long, and the sample was dried unevenly, which was easy to breed microorganisms and affect the quality of the Sanguisorba officinalis extract powder.
[0105] 2.1 Drying process investigation
[0106] 2.1.1 Sample: Sanguisorba officinalis precipitate prepared according to the “standard before revision”.
[0107] 2.2.2 Scheme: Take 3 portions of Sanguisorba officinalis precipitate and dry them by ventilation drying, drying oven drying, freeze vacuum drying, spray drying and low temperature vacuum belt drying respectively. The results are shown in Table 1.
[0108] Table 1 Drying method comparison results
[0109]
[0110] Results: As shown in Table 1, the low-temperature vacuum belt drying method has the shortest drying time, low moisture content, and uniform moisture content, while the other methods have long drying times and uneven drying. Therefore, the low-temperature vacuum belt drying method is preferred.
[0111] 2.2 Screening of parameters for low-temperature vacuum belt drying method
[0112] 2.2.1 Sample: Sanguisorba officinalis precipitate prepared according to the “standard before revision”.
[0113] 2.2.2 Drying temperature screening
[0114] 2.2.2.1 Plan: Take 3 samples each and set the drying temperature to 20℃, 40℃, 60℃ and 80℃ for 1 hour respectively. The results are shown in Table 2.
[0115] Table 2 Drying temperature comparison results
[0116]
[0117]
[0118] Results: As shown in Table 2, when the drying temperature is 20-80°C, the moisture content is lower than 2.0%, but the gallic acid content decreases when the drying temperature is 80°C. Taking all factors into consideration, the drying temperature of 60°C is the preferred temperature for low-temperature vacuum belt drying.
[0119] 2.2.3 Screening of track speed
[0120] 2.2.3.1 Plan: Take 3 samples each, set the track speed to 130mm / min, 135mm / min, and 150mm / min respectively, set the drying temperature to 60℃, and dry for 1 hour. The results are shown in Table 3.
[0121] Table 3 Track speed comparison results
[0122]
[0123] Results: As shown in Table 3, when the crawler speed was 130-150 mm / min, the moisture content was lower than 1.5%, but the gallic acid content was the highest at 135 mm / min. Taking all factors into consideration, 135 mm / min was the optimal crawler speed for low-temperature vacuum belt drying.
[0124] 2.2.4 Feed pump frequency selection
[0125] 2.2.4.1 Plan: Take 3 samples each, dry them for 1 hour at a crawler speed of 135 mm / min, a drying temperature of 60°C, and feed pump frequencies of 30, 40, and 50 Hz. The results are shown in Table 4.
[0126] Table 4 Feed pump frequency comparison results
[0127] Sample No. Feed pump frequency (Hz) Moisture content (%) Gallic acid content (%) 1 30 1.32 1.20 2 40 1.29 1.23 3 50 1.28 1.21
[0128] Results: As shown in Table 4, when the feed pump frequency was 30-50 Hz, the moisture content was lower than 1.5%, but the gallic acid content was the highest at 40 Hz. Taking all factors into consideration, 40 Hz was the optimal feed pump frequency for low-temperature vacuum belt drying.
[0129] 2.2.5 Screening of crushing frequency
[0130] 2.2.5.1 Plan: Take 3 samples each, dry them for 1 hour at a crawler speed of 135 mm / min, a drying temperature of 60°C, a feed pump of 40 Hz, and a crushing frequency of 30 Hz, 40 Hz, and 50 Hz respectively. The results are shown in Table 5.
[0131] Table 5 Comparison results of crushing frequency
[0132] Sample No. Crushing frequency (Hz) Moisture content (%) Gallic acid content (%) 1 30 1.31 1.20 2 40 1.30 1.23 3 50 1.28 1.21
[0133] Results: As shown in Table 5, when the feed pump frequency was 30-50 Hz, the moisture content was lower than 1.5%. When the crushing frequency was 40 Hz, the gallic acid content was the highest. Taking all factors into consideration, the crushing frequency of 40 Hz was the preferred crushing frequency for low-temperature vacuum belt drying.
[0134] 2.2.6 Screening of drying time
[0135] 2.2.6.1 Plan: Take 3 samples each, dry them for 1h, 2h and 3h respectively at a crawler speed of 135mm / min, a drying temperature of 60℃, a feed pump of 40Hz and a crushing frequency of 40Hz. The results are shown in Table 6.
[0136] Table 6 Drying time comparison results
[0137]
[0138] Results: As shown in Table 6, when the drying time is 1-3h, the moisture content is lower than 1.5%, and the gallic acid content is the highest when the drying time is 1h. Considering comprehensively, 1h is the optimal drying time for low-temperature vacuum belt drying.
[0139] Conclusion: The optimal parameters for low-temperature vacuum belt drying are: drying temperature 60℃, vacuum degree -0.075Mpa, crawler speed 135mm / min, feed pump 40Hz, crushing frequency 40Hz, and drying time 1h.
[0140] 3. Identification
[0141] 3.1 Experimental Instruments
[0142] Silicone thin layer G plate (Qingdao Petrochemical Branch), silicone thin layer H plate (Qingdao Offshore Engineering Branch), silicone thin layer plate GF254 (Qingdao Offshore Engineering Branch), polyamide film plate (Qingdao Petrochemical Branch), three-purpose UV instrument (Shanghai Anting Electronic Instrument Factory).
[0143] 3.2 Experimental reagents
[0144] 5% phosphomolybdic acid ethanol solution (Tianjin Ruijinte Chemical Co., Ltd.), methanol (Tianjin Jinnan District Xianshuigu Town Industrial Zone Co., Ltd.), dichloromethane (Tianjin Komeo Chemical Reagent Co., Ltd.), ethyl acetate (Tianjin Komeo Chemical Reagent Co., Ltd.), glacial acetic acid (Chongqing Chuandong Chemical Co., Ltd.), acetone (Tianjin Komeo Chemical Reagent Co., Ltd.), 3% aluminum chloride ethanol solution (Chongqing Chuandong Chemical Co., Ltd.), 10% sulfuric acid ethanol solution (Chongqing Chuandong Chemical Co., Ltd.). Hibiscus mume reference medicinal materials (China Food and Drug Inspection Institute), rutin reference substance (China Food and Drug Inspection Institute), Sanguisorba officinalis saponin reference medicinal material solution (China Food and Drug Inspection Institute), Sanguisorba officinalis saponin reference substance (China Food and Drug Inspection Institute), compound Hibiscus mume nasal ointment (Guizhou Liangji Pharmaceutical Co., Ltd.).
[0145] 3.3 Thin layer chromatography identification of Sanguisorba officinalis
[0146] 3.3.1 Preparation of test sample, reference sample and reference medicinal material solution
[0147] Preparation of test solution: Weigh 20g of compound Hibiscus mutabilis nasal ointment sample, add 30mL of methanol, heat and reflux at 80℃ for 40min, filter, evaporate the filtrate to dryness, disperse the residue with warm purified water, apply it to a D-101 macroporous resin column, first wash with purified water until there is no turbidity, then elute with 100mL of 50% and 75% ethanol respectively, collect the 75% ethanol eluate, evaporate to dryness, add 5mL of methanol to dissolve the residue to obtain the test solution.
[0148] Preparation of control medicinal material solution: Take 2 g of Sanguisorba officinalis control medicinal material and prepare the control medicinal material solution in the same way as the test solution.
[0149] Preparation of reference solution: Take an appropriate amount of Sanguisorba officinalis saponin reference substance and add methanol to prepare a 0.9 mg / mL reference solution.
[0150] 3.3.2 Development agent investigation
[0151] According to the thin layer chromatography method, take 1ul of the test solution, reference solution, and reference medicinal material solution under "3.3.1" and spot them on the same silica gel G plate, respectively, and use A: ethyl acetate-methanol-water (7:1:0.2), B: dichloromethane-methanol (7:1), and C: ethyl acetate-methanol-water-glacial acetic acid (8:1:1:0.2) as the developing solvents in sequence, take out, dry, spray 5% phosphomolybdic acid ethanol solution at 105℃ for color development, and check its separation, color, size and roundness. Figure 1 .
[0152] Results: Through the investigation of three developing agents, Figure 1It can be seen that in the tested samples, the control medicinal materials and the reference substances have the same spots on the same horizontal line, and when the developing agent is A: "ethyl acetate-methanol-water (7:1:0.2)", the spots appear in the middle of the thin layer plate, and the separation, color, size and roundness all meet the requirements, so it is the preferred developing agent.
[0153] 3.3.3 Study on colorimetric reagent
[0154] According to the thin layer chromatography method, take 1ul of the test solution, reference solution, and reference medicinal material solution under "3.3.1" and spot them on the same silica gel G plate, develop them with ethyl acetate-methanol-water (7:1:0.2) as the developing solvent, take them out, dry them, spray them with A: 5% phosphomolybdic acid ethanol solution and B: 20% sulfuric acid ethanol solution, develop them at 105℃, and observe their separation degree, color, size, and roundness. Figure 2 .
[0155] Results: Two display reagents were tested. Figure 2 It can be seen that the tested samples, control medicinal materials and reference substances have the same spots at the same level, and when the display reagent is B: "5% phosphomolybdic acid ethanol solution", the spot appears most obviously in the middle of the thin layer. Taking into account the color size of the spots and the separation of the dots, it is finally determined that the color developer is "5% phosphomolybdic acid ethanol solution".
[0156] 3.3.4 Silicone plate inspection
[0157] According to the thin layer chromatography method, take 1ul of the test solution, reference solution, and reference medicinal material solution under "3.3.1" and spot them on A: silica gel G thin layer, B: silica gel H thin layer, and C: GF254 thin layer, develop them with ethyl acetate-methanol-water (7:1:0.2) as the developing agent, take them out, dry them, spray them with 5% phosphomolybdic acid ethanol solution, and develop them at 105℃. Observe the degree of separation, color, size, and roundness. Figure 3 .
[0158] Results: Through the investigation of three kinds of silica gel plates, Figure 3 It can be seen that the tested samples, control herbs and reference substances all have the same spots, but the spots on the silica gel G plate are the most obvious. Considering the color and size of the spots and the separation of the dots, it was finally decided to select thin layer plate A: "Silica gel G thin layer plate".
[0159] 3.3.5 Methodological validation
[0160] 3.3.5.1 Reproducibility
[0161] Take 10 batches of compound Hibiscus mutabilis nasal ointment (20230901, 20230902, 20230903, 20230904, 20230905, 20230906, 20230907, 20230908, 20230909, 20230910), prepare the test solution, reference drug solution and reference substance solution according to "3.3.1" respectively, take 1ul of each and spot them on the same silica gel G plate in sequence, develop with ethyl acetate-methanol-water (7:1:0.2) as the developing solvent, take out, dry, spray with 5% phosphomolybdic acid ethanol solution respectively, develop color at 105℃, see Figure 4 .
[0162] Results: By Figure 4 It can be seen that in the 10 batches of samples tested, spots of the same color appeared on the silica gel G plate at the positions corresponding to the reference substances and reference medicinal materials, indicating good reproducibility.
[0163] 3.3.5.2 Exclusivity
[0164] According to the thin layer chromatography method, prepare the test solution, reference solution, reference medicinal material solution and negative sample solution according to the method under "3.3.1" respectively, take 1ul of each sample and spot it on the same silica gel G plate, develop it with ethyl acetate-methanol-water (7:1:0.2) as the developing solvent, take it out, dry it, spray it with 5% phosphomolybdic acid ethanol solution respectively, and develop it at 105℃. As a result, in the tested sample, spots of the same color appear at the corresponding positions of the reference substance and reference medicinal material, and the spots are well separated. There is no interference with the negative, as shown. Figure 5 .
[0165] 3.3.5.3 Durability
[0166] 3.3.5.3.1 Comparison of different thin layer plates
[0167] Take 1ul of each of the test solution, reference solution and reference medicinal material solution under "3.3.1" and spot them on the silica gel G thin layer plate of "Qingdao Ocean Chemical Co., Ltd." and the silica gel G thin layer plate of "Sinopharm Chemical Drug Testing Co., Ltd." respectively, develop them with ethyl acetate-methanol-water (7:1:0.2) as the developing agent, take them out, dry them, spray them with 5% phosphomolybdic acid ethanol solution respectively, and develop them at 105℃. Figure 6 , Figure 7 .
[0168] Results: By Figure 6 , Figure 7 It can be seen that after the silica gel G thin layer plates from the two manufacturers were developed, they all showed clear spots, the separation met the requirements, and the Rf value was moderate; therefore, this method has good durability.
[0169] 3.3.5.3.2 Temperature and humidity methodology investigation
[0170] According to the thin layer chromatography method, 1ul of the test solution, reference solution, and reference medicinal material solution under "3.3.1" were spotted on a silica gel G thin layer. Under the same conditions, at the same temperature (20°C) and different humidity (low humidity 43% and high humidity 73%); at the same humidity (73%) and different temperatures (low temperature (4°C) and high temperature (20°C), they were developed with ethyl acetate-methanol-water (7:1:0.2), taken out, dried, sprayed with 5% phosphomolybdic acid ethanol solution, and developed at 105°C. The results are shown in Figure 8 , Fig. 9 , Fig.10 , Fig.11 .
[0171] Depend on Figure 8 , Fig. 9 , Fig.10 , Fig.11 It can be seen that spots of the same color are displayed at corresponding positions in the test sample chromatogram, the reference medicinal material chromatogram and the reference sample chromatogram. Combined with the spot color size and dot separation, it is proved that better identification chromatograms can be obtained under different temperature and humidity conditions.
[0172] 3.4 Thin layer chromatography identification of Hibiscus mutabilis leaves
[0173] 3.4.1 Preparation of test sample, reference sample and reference medicinal material solution
[0174] Preparation of the test solution: Take 20g of compound Hibiscus mutabilis leaf ointment, add 30mL of methanol, reflux at 80℃ for 30 minutes, filter, evaporate the filtrate, add 10mL of pure water, extract twice with petroleum ether (30-60℃), remove the petroleum ether layer, and then extract twice with ethyl acetate, 10mL each time, to obtain the test solution.
[0175] Preparation of control medicinal material solution: Take 20 g of Hibiscus mutabilis leaf control medicinal material and prepare the control medicinal material solution in the same way as the test solution.
[0176] Preparation of reference solution: Take an appropriate amount of rutin reference substance and add methanol to make a 0.1 mg / mL standard solution.
[0177] 3.4.2 Development agent investigation
[0178] According to the thin layer chromatography method, take 1ul of the test solution, reference solution, reference medicinal material solution and negative solution under "3.4.1" and spot them on the same silica gel G plate, respectively, and use A: ethyl acetate-methanol-water (8:1:1), B: ethyl acetate-methanol-water (7:5:1), C: ethyl acetate-methanol-water-glacial acetic acid (15:5:1:1) as the developing agent to develop them in sequence, take them out, dry them, spray them with 3% aluminum trioxide ethanol solution, blow them dry with a hair dryer, and there will be obvious fluorescent spots at 365nm of UV light. Fig.12 .
[0179] Results: Through the investigation of three developing agents, Fig.12 It can be seen that in the tested samples, the control medicinal materials and the reference substances have the same spots on the same horizontal line and when the developing agent is C: ethyl acetate-methanol-water-glacial acetic acid (15:5:1:1), the spots appear in the middle of the thin layer plate, and the separation, color, size and roundness all meet the requirements, so it is the preferred developing agent.
[0180] 3.4.3 Study on colorimetric reagent
[0181] According to the thin layer chromatography method, 1ul of the test solution, reference solution and reference medicinal material solution under "3.4.1" were spotted on the same silica gel G plate, and developed with ethyl acetate-methanol-water-glacial acetic acid (15:5:1:1) as the developing solvent. The plate was taken out, dried, sprayed with A (3% trichloroaluminum ethanol solution) and B (10% sulfuric acid ethanol solution), dried with a hair dryer, and detected at 365nm of UV light. Fig.13 .
[0182] Depend on Fig.13 It can be seen that in the tested samples, fluorescent spots of the same color appear at the corresponding positions of the reference substance and the reference medicinal material, and in the case of reagent A: 3% aluminum chloride ethanol solution, the spots appear most obviously in the middle of the thin layer. Considering the color size of the spots and the separation of the dots, it was finally determined that the color developer was A (3% aluminum chloride ethanol solution).
[0183] 3.4.4 Silicone plate inspection
[0184] According to the thin layer chromatography method, 1ul of the test solution, reference solution and reference medicinal material solution under "3.4.1" were spotted on A (GF254 thin layer plate), B (polyamide film plate) and C (HF254 thin layer plate) in sequence, and developed with ethyl acetate-methanol-water-glacial acetic acid (15:5:1:1) as the developing agent. Take out, dry, spray with 3% aluminum chloride ethanol solution, blow dry with a hair dryer, and detect at UV light 365nm. Fig.14 .
[0185] Results: Through the investigation of three kinds of silica gel plates, Fig.14 It can be seen that the tested samples, control medicinal materials and reference substances all have the same fluorescent spots, but the spots on B (polyamide film plate) are the most significant. Considering the color and size of the spots and the separation of the dots, thin layer plate B (polyamide film plate) was finally selected.
[0186] 3.4.5 Methodological validation
[0187] 3.4.5.1 Reproducibility
[0188] Take 10 batches of compound Hibiscus mutabilis nasal ointment (20230901, 20230902, 20230903, 20230904, 20230905, 20231001, 20231002, 20231003, 20231004, 20231005), prepare the test solution, reference drug solution and reference substance solution according to "3.4.1" respectively, take 1ul of each and spot them on the same polyamide film plate in sequence, develop with ethyl acetate-methanol-water-glacial acetic acid (15:5:1:1) as the developing agent, take out, dry, spray with 3% aluminum chloride ethanol solution, blow dry with a hair dryer, detect at UV light 365nm, see Fig.15 .
[0189] Results: By Fig.15 It can be seen that in the 10 batches of samples tested, fluorescent spots of the same color appeared on the polyamide film plate at the positions corresponding to the reference substances and reference medicinal materials, indicating good reproducibility.
[0190] 3.4.5.2 Exclusivity
[0191] According to the thin layer chromatography method, prepare the test solution, reference solution, reference medicinal material solution and negative sample solution according to the method under "3.4.1" respectively, take 1ul of each solution and spot it on the same polyamide film plate, develop it with ethyl acetate-methanol-water-glacial acetic acid (15:5:1:1) as the developing agent, take it out, dry it, spray it with 3% aluminum chloride ethanol solution respectively, blow it dry with a hair dryer, and detect it under UV light at 365nm; as a result, in the tested sample, fluorescent spots of the same color are shown at the corresponding positions of the reference substance and reference medicinal material, and the spots are well separated, and there is no interference with the negative, see Fig.16 .
[0192] 3.4.5.3 Durability
[0193] 3.4.5.3.1 Comparison of different thin layer plates
[0194] Take 1ul of the test solution, reference solution and reference medicinal material solution under item "3.3.1" respectively, spot them on the polyamide film plates of "Qingdao Ocean Chemical Co., Ltd." and "Sinopharm Chemical Test Drug Co., Ltd." respectively, develop them with ethyl acetate-methanol-water-glacial acetic acid (15:5:1:1) as the developing agent, take them out, dry them, spray them with 3% aluminum chloride ethanol solution respectively, blow them dry with a hair dryer, and detect them under UV light at 365nm. The results show that after the polyamide film plates of the two manufacturers are developed, the spots are clear, the separation meets the requirements, and the Rf value is moderate; therefore, this method has good durability.
[0195] 3.3.5.3.2 Temperature and humidity methodology investigation
[0196] According to the thin layer chromatography method, 1ul of the test solution, reference solution and reference medicinal material solution under "3.4.1" were spotted on a polyamide film plate. Under the same conditions, at the same temperature (20°C) and different humidity (A: low humidity 43% and B: high humidity 73%), they were developed with ethyl acetate-methanol-water-glacial acetic acid (15:5:1:1), taken out, dried, sprayed with 3% aluminum chloride ethanol solution, dried with a hair dryer, and detected at 365nm of UV light. The results are shown in Table 1. Fig.17 .
[0197] Depend on Fig.17 It can be seen that fluorescent spots of the same color are displayed at the corresponding positions in the test sample chromatogram, the reference medicinal material chromatogram and the reference sample chromatogram. The combined color size of the spots and the separation of the dots prove that better identification chromatograms can be obtained under different humidity conditions.
[0198] According to the thin layer chromatography method, 1ul of the test solution, reference solution and reference medicinal material solution under "3.4.1" were spotted on a polyamide film plate. Under the same conditions, at the same humidity (73%), at different temperatures (A: low temperature 4°C and B: high temperature 20°C), they were developed with ethyl acetate-methanol-water-glacial acetic acid (15:5:1:1), taken out, dried, sprayed with 3% aluminum chloride ethanol solution, dried with a hair dryer, and detected at 365nm of UV light. The results are shown in Table 1. Fig.18 .
[0199] Depend on Fig.18 It can be seen that fluorescent spots of the same color are displayed at the corresponding positions in the test sample chromatogram, the reference medicinal material chromatogram and the reference sample chromatogram. The combined color size of the spots and the separation of the dots prove that better identification chromatograms can be obtained under different temperature conditions.
[0200] Although the present invention has been described in detail above using general descriptions, specific implementation methods and experiments, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention are within the scope of protection claimed by the present invention.
Claims
1. A method for preparing a compound Hibiscus mutabilis nasal ointment, wherein the ointment comprises: 500 g of Hibiscus mutabilis leaves, 100 g of Sanguisorba officinalis, 40 g of Borneolum, 20 g of menthol, 80 ml of edible vinegar essence, 40 g of salt, 627 g of lanolin, 50 g of white vaseline, and 70 g of paraffin; characterized in that: The preparation method of the nasal ointment is: (1) Take the leaves of Hibiscus mutabilis from the above four herbs, add water and boil twice, each time for 1 hour, filter, combine the decoctions, and concentrate at normal pressure to a thick paste with a relative density of 1.30 at 60° C., add 0.5% potassium sorbate and mix well to obtain a thick paste of Hibiscus mutabilis leaves, which is set aside; (2) Take the Sanguisorba officinalis, grind it into coarse powder, add water and boil for 1 hour, cool the filtrate to 50°C, add salt, stir while adding, make the precipitation complete, let it stand, filter, and low-temperature vacuum belt drying to obtain Sanguisorba officinalis extract powder, which is set aside; (3) Take borneol and menthol, crush them through a 60-mesh sieve, and mix and stir until they become a co-melt; (4) Take the above-mentioned Hibiscus mutabilis leaf paste and Sanguisorba officinalis extract powder, mix them with edible vinegar essence and stir for 20 minutes, add borneol and menthol eutectic to make the mixture evenly mixed; (5) After the lanolin, white vaseline and paraffin are heated and melted respectively, they are sterilized at 100°C for 1 hour, then mixed evenly, cooled to 50°C, filtered through a 120-mesh sieve, and then mixed with the above-mentioned drug solution, stirred evenly, kept at 50°C, and stirred at high speed under reduced pressure for 30 minutes, and then cooled to room temperature with conventional stirring, made into a specified amount, potted, sealed, and packaged.
2. The preparation method according to claim 1, characterized in that: The specific conditions of the low-temperature vacuum belt drying in step (2) are: drying temperature 20°C-80°C, vacuum degree -0.075Mpa, crawler speed 130-150mm / min, feed pump 30-40Hz, and crushing frequency 30Hz-50Hz.
3. The preparation method according to claim 2, characterized in that: The specific conditions of the low-temperature vacuum belt drying in step (2) are: drying temperature 60°C, vacuum degree -0.075Mpa, crawler speed 135mm / min, feed pump 40Hz, and crushing frequency 40Hz.
4. A thin layer identification method for the compound Hibiscus mutabilis nasal ointment prepared by the preparation method according to any one of claims 1 to 3, characterized in that: The thin layer identification includes Sanguisorba officinalis thin layer identification and Hibiscus mutabilis leaf thin layer identification.
5. The thin layer identification method according to claim 4, characterized in that: The thin-layer identification method of Sanguisorba officinalis is as follows: weigh 15-25g of compound Hibiscus mutabilis nasal ointment sample, add 20-40mL of methanol, heat and reflux at 60-100°C for 30-60min, filter, evaporate the filtrate to dryness, add purified water to the residue and disperse it in warm water, apply it to a D-101 macroporous resin column, first wash it with purified water until there is no turbidity, then elute it with 50% and 75% ethanol 100mL each, collect the 75% ethanol eluate, evaporate to dryness, add 5-10mL of methanol to the residue to dissolve it, and obtain a test solution; take 2g of Sanguisorba officinalis reference medicinal material, and mix it with the test solution The preparation method comprises the following steps: preparing a reference medicinal material solution; taking an appropriate amount of Sanguisorba officinalis saponin reference substance, adding methanol to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, taking 1-3 μl of the test solution, the reference medicinal material solution and the reference substance solution, respectively, and spotting them on the same silica gel G plate, using ethyl acetate-methanol-water with a ratio of 7:1:0.2 as a developing solvent, developing, taking out, drying, spraying with 5% phosphomolybdic acid ethanol solution, and developing at 105°C. In the test sample chromatogram, spots of the same color appear at the corresponding positions of the reference medicinal material chromatogram and the reference substance chromatogram.
6. The thin layer identification method according to claim 5, characterized in that: The thin-layer identification method of Sanguisorba officinalis is as follows: weigh 15-20g of compound Hibiscus mutabilis nasal ointment sample, add 20-30mL of methanol, heat and reflux at 60-80°C for 30-40min, filter, evaporate the filtrate to dryness, add purified water to the residue and disperse it in warm water, apply it to a D-101 macroporous resin column, first wash it with purified water until there is no turbidity, then elute it with 50% and 75% ethanol 100mL each, collect the 75% ethanol eluate, evaporate to dryness, add 5-8mL of methanol to the residue to dissolve, and obtain a test solution; take 2g of Sanguisorba officinalis reference medicinal material, and Preparation method: prepare a reference medicinal material solution; take an appropriate amount of Sanguisorba officinalis saponin reference substance, add methanol to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, take 1-2 μl of the test solution, the reference medicinal material solution and the reference substance solution, respectively, and spot them on the same silica gel G plate, use ethyl acetate-methanol-water with a ratio of 7:1:0.2 as a developing solvent, develop, take out, dry, spray with 5% phosphomolybdic acid ethanol solution, and develop at 105°C. In the test sample chromatogram, spots of the same color appear at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
7. The thin layer identification method according to claim 6, characterized in that: The thin layer identification method of Sanguisorba officinalis is as follows: weigh 20g of compound Hibiscus mutabilis nasal ointment sample, add 30mL of methanol, heat and reflux at 80°C for 40min, filter, evaporate the filtrate to dryness, add purified water to the residue and disperse it in warm water, apply it to a D-101 macroporous resin column, first wash it with purified water until there is no turbidity, then elute it with 100mL of 50% and 75% ethanol respectively, collect the 75% ethanol eluate, evaporate to dryness, add 5mL of methanol to the residue and dissolve it to obtain a test solution; take 2g of Sanguisorba officinalis reference medicinal material, prepare the same preparation method of the test solution Control medicinal material solution; take an appropriate amount of Sanguisorba officinalis saponin reference substance, add methanol to prepare a 0.9 mg / mL reference substance solution; according to the thin layer chromatography test, take 1 μl of the test solution, the control medicinal material solution and the reference substance solution, respectively, and spot them on the same silica gel G plate, use ethyl acetate-methanol-water with a ratio of 7:1:0.2 as the developing solvent, develop, take out, dry, spray with 5% phosphomolybdic acid ethanol solution, and develop color at 105°C. In the test sample chromatogram, spots of the same color appear at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
8. The thin layer identification method according to claim 4, characterized in that: The identification method of the Hibiscus mutabilis leaf medicinal material is as follows: 15-25 g of the compound Hibiscus mutabilis leaf ointment is added with 25-35 mL of methanol, and after refluxing at 60-100° C. for 20-40 minutes, the ointment is filtered, 10 mL of pure water is added after the filtrate is evaporated, and the ointment is extracted twice with petroleum ether at 30-60° C., the petroleum ether layer is removed, and then the ointment is extracted twice with ethyl acetate, each time with 5-15 mL, to obtain a test solution; 20 g of the Hibiscus mutabilis leaf control medicinal material is taken, and a control medicinal material solution is prepared in the same manner as the preparation method of the test solution; an appropriate amount of rutin reference substance is taken, and methanol is added to prepare a Prepare a 0.1 mg / mL standard solution; according to the thin layer chromatography test, take 1-3 μl of the test solution, the control medicinal material solution and the reference substance solution, respectively, and spot them on the same polyamide film plate, use ethyl acetate-methanol-water-glacial acetic acid with a ratio of 15:5:1:1 as the developing agent, develop, take out, dry, spray with 3% trichloroaluminum ethanol solution, blow dry with a hair dryer, and detect under UV light 365nm; in the test sample chromatogram, at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram, fluorescent spots of the same color appear.
9. The thin layer identification method according to claim 8, characterized in that: The identification method of the Hibiscus mutabilis leaf medicinal material is as follows: 15-20 g of the compound Hibiscus mutabilis leaf ointment is added with 25-30 mL of methanol, and after refluxing at 60-80° C. for 20-30 minutes, the mixture is filtered, 10 mL of pure water is added after the filtrate is evaporated, and the mixture is extracted twice with petroleum ether at 30-60° C., the petroleum ether layer is removed, and then the mixture is extracted twice with ethyl acetate, each time with 5-10 mL, to obtain a test solution; 20 g of the Hibiscus mutabilis leaf control medicinal material is taken, and a control medicinal material solution is prepared in the same manner as the preparation method of the test solution; an appropriate amount of rutin reference substance is taken, and methanol is added to prepare a 0.1mg / mL standard solution; according to the thin layer chromatography test, 1-2μl of the test solution, control medicinal material solution and reference substance solution are respectively spotted on the same polyamide film plate, and ethyl acetate-methanol-water-glacial acetic acid with a ratio of 15:5:1:1 is used as the developing agent, and the plate is developed, taken out, dried, sprayed with 3% trichloroaluminum ethanol solution, blown dry with a hair dryer, and detected under UV light at 365nm; in the test sample chromatogram, fluorescent spots of the same color are shown at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
10. The thin layer identification method according to claim 9, characterized in that: The identification method of the Hibiscus mutabilis leaf medicinal material is as follows: 20 g of the compound Hibiscus mutabilis leaf ointment is added with 30 mL of methanol, and after refluxing at 80° C. for 30 minutes, the ointment is filtered, and after the filtrate is evaporated, 10 mL of pure water is added, and the ointment is extracted twice with petroleum ether at 30 to 60° C., the petroleum ether layer is removed, and then the ointment is extracted twice with ethyl acetate, each time with 10 mL, to obtain a test solution; 20 g of the control medicinal material of Hibiscus mutabilis leaf is taken, and a control medicinal material solution is prepared in the same manner as the preparation method of the test solution; an appropriate amount of rutin reference substance is taken, and methanol is added to make a 0.1 mg / m L of standard solution; according to the thin layer chromatography test, 1-3 μl of the test solution, the control medicinal material solution and the reference substance solution are respectively spotted on the same polyamide film plate, and ethyl acetate-methanol-water-glacial acetic acid with a ratio of 15:5:1:1 is used as the developing agent, the plate is developed, taken out, dried, sprayed with 3% trichloroaluminum ethanol solution, blown dry with a hair dryer, and detected under UV light at 365nm; in the test sample chromatogram, fluorescent spots of the same color are shown at the corresponding positions of the control medicinal material chromatogram and the reference substance chromatogram.
Citation Information
Patent Citations
Method for detecting compound hibiscus nose-applying ointment
CN110531021A
Compound hibiscus mutabilis nose-coating gel and preparation method thereof
CN111135140A
Thin-layer chromatography identification method for carbonized sanguisorba root in gynaecological Faihong drink capsule
CN116136524A
